Osstem Implant Targets Middle East and Africa... Aiming at Medical Tourism Demand

Africa's First 'Digital Dental' Education Program Launched

Osstem Implant is expanding its sales network by establishing overseas subsidiaries with the goal of achieving global sales of 2 trillion KRW by 2026, while also working to increase its market share in the Middle East and Africa.

Osstem Implant's Middle East subsidiary announced on the 27th that it conducted implant clinical training over two days starting from the 16th for dental university residents and dentists in Tanzania and Tunisia, Africa.

Ostem Implant Middle East branch giving a lecture at the Tanzania Dental University.
[Photo by Ostem Implant]

Osstem Implant explained that this program, conducted as part of the Korea Trade-Investment Promotion Agency (KOTRA)'s 'Global ESG (Environment, Social, Governance) Plus Project,' is the first digital dental education in Africa.

The Middle East region is a representative medical tourism destination. Among Middle Eastern countries, the United Arab Emirates (UAE) has a domestic market of about 10 million people, which is not large, but the proportion of medical tourists coming from abroad is high. According to KOTRA, dental, dermatology, and orthopedics are the most popular medical tourism treatments in the UAE, and the number of dentists in the UAE has steadily increased by nearly 11% annually from 2016 to 2020.

Jang Dae-hee, head of Osstem Implant's Middle East subsidiary, said, "As the global dental industry is experiencing a wave of 'digitalization,' our company introduced digital technology for the first time to dental university residents and dentists in Africa," adding, "We plan to continue clinical training in Africa to advance medical technology in local communities."

Established in 2020, Osstem Implant's Middle East subsidiary conducts sales activities targeting a total of 26 countries, including Middle Eastern countries such as the UAE, Saudi Arabia, and Kuwait, as well as African countries such as Egypt, Morocco, and South Africa. The main products sold by Osstem Implant's Middle East subsidiary are implants and large medical equipment.

Meanwhile, Osstem Implant plans to establish new subsidiaries in Portugal and the Netherlands within this year. Currently, Osstem Implant operates 32 overseas subsidiaries in 28 countries and exports and sells products in 92 countries. By 2026, it plans to establish 50 overseas subsidiaries in 46 countries to expand its global sales network.

This content was produced with the assistance of AI translation services.